Penn Pharma, a UK bioscience company, has produced the first batch of coated tablets in its new £14.4m contained manufacturing facility in Tredegar, South Wales.
The 15,000ft2 plant has been built in less than 12 months for the clinical and commercial manufacture of tablets and capsules and will allow Penn Pharma to build on its expertise in the production and packing of specialist drugs for the worldwide market.
Richard Yarwood, Chief Executive of Penn Pharma, said: ‘It is a monumental day for Penn Pharma. In less than one year we have built a world class facility for contained manufacturing and produced our first batch of coated tablets. This gives our customers even greater confidence that Penn Pharma can meet the challenging timelines they require to get their products to market.’
Mark Dean-Netscher, Chief Operating Officer at Penn Pharma, added: ‘This success is the result of hard work and determination to get us to this stage in such a short space of time. A facility of this complex nature was a tight build in the timeframe, but we have demonstrated that when Penn Pharma commits to something, we always deliver.’
